North America Dialysis Market value was valued at USD 29.2 billion in 2019 and is expected to witness 3.7% CAGR from 2019 to 2026.
Get more details on this report - Request Free Sample PDF
Increasing prevalence of renal diseases coupled with rising geriatric population will stimulate the adoption of dialysis market in North America. According to the National Kidney Foundation (NKF), over 500,000 American patients received dialysis treatment in 2016. Dialysis is used to purify & filter blood to maintain fluid and electrolyte balance in the body. This procedure is mainly adopted in patients with kidney failure owing to physical injury, high blood pressure or diabetes among others. Growing adoption of dialysis treatment to maintain body’s balance by eliminating extra salt or water in order to regulate potassium, sodium and bicarbonate levels in the blood will foster the North America dialysis market growth over the forthcoming years.
Technological innovations such as availability of home dialysis units and less invasive vascular access to the procedure will positively impact the North America dialysis industry growth. Home-based dialysis units are increasingly preferred by patients owing to its ease-of-use, independence and convenience. Moreover, such advancements ensure short term relief and reduced risk of kidney transplantation. Aforementioned factors will thus upsurge the demand for dialysis treatment during the forthcoming years.
North America Market Share, By Type
Haemodialysis segment held more than USD 25.5 billion revenue in 2019 and will witness considerable growth over the forecast period. Haemodialysis is the process used to filter excess water and waste from the blood in case of kidney failure. The process involves usage of a dialyzer kept outside the body, that helps to maintain electrolyte and blood pressure in the body. The process also ensures regulated potassium and sodium levels in the blood, resulting in regulated blood pressure and hormones required for red blood cell formation. Growing demand for minimally invasive procedure that involves reduced risk of infection and kidney replacement will augment haemodialysis segment growth over the analysis timeframe.
North America Market Size, By Product & Services
Services segment is projected to show around 3.5% CAGR throughout the analysis period. Doctors and clinicians prefer in-centre dialysis treatment due to its accessibility and improved patient outcomes. In-centre dialysis is performed by medically trained professionals and nephrologists, usually 2-3 times in a week. Growing adoption of dialysis treatment in the dialysis centres as well as hospital facilities will foster the demand for dialysis service in North America.
North America Market Trends, By End-use
Home dialysis segment has held substantial revenue in 2019 and is projected to exceed USD 11.0 billion by 2026. Segment growth is attributed to various benefits offered by home dialysis over in-centre dialysis such as portability, flexible scheduling and easy patient mobility. Moreover, the patient can perform dialysis while travelling without any complications. High preference for home dialysis treatment among the geriatric patient pool suffering from end-stage renal disease (ESRD) will further drive the industry expansion. Home dialysis makes the treatment feasible and offers a better alternative to kidney transplantation, thus escalating the market growth.
North America Market Value, By Country
U.S. dialysis market dominated the overall North America dialysis market and is anticipated to witness 3.8% CAGR over the forecast timeframe. Growing burden of renal diseases in the country coupled with adoption of sedentary lifestyle has led to increasing prevalence of diabetes and high blood pressure. According to the National Kidney Foundation, around 37 million adults in the U.S. were diagnosed with kidney diseases in 2016. Technological advancements and strong foothold of key industry players in the country will further drive the U.S. dialysis market progress during the upcoming years.
Competitive Market Share
Some of the major players involved in market include DaVita, Baxter International, Medtronic, Rogosin Institute, Satellite Healthcare, U.S. Renal Care among others. These companies are adopting various inorganic strategies such as collaborations, mergers, acquisitions and product innovation to maintain their market position. For instance, in March 2017, the U.S. Renal Care announced expansion of its dialysis clinic in Dallas. This expansion enabled the company to broaden its business operations and increase customer base.
Dialysis is a surgical procedure used for filtration and purification of blood with removal of access blood and salts. In 1913, the first dialysis procedure was developed by Leonard Rowntree and John Abel of Johns Hopkins Hospital in the U.S. The procedure was successfully carried in animals and later adopted in human kidney treatments. In 1945, Gordon Murray of the University of Toronto developed a dialysis machine to treat patients with acute renal failure. There were several developments in dialysis treatment during 1940’s. For instance, Dr. Willem Kolff gave blueprints of kidney machine to George Thorn of Peter Bent Brigham Hospital in Boston for further development. These developments led to development and manufacturing of Kolff’s dialysers in 1954. Later, the Kolff- Brigham dialysers were used in treatment of injured American soldiers. Moreover, development of technologically advanced treatment procedures such as home-based dialysis has increased the treatment demand over the recent years. Growing inclination towards dialysis as an alternative to kidney transplantation will offer several growth opportunities in the foreseeable future.